Matthew Fust is an experienced board member, serving on the boards of several biotechnology companies, including ArsenalBio, Atara Biotherapeutics, Crinetics Pharmaceuticals, Neumora, and Ultragenyx Pharmaceutical Inc. Since March 2014, Matthew has also held board positions at MacroGenics, Inc. and Dermira, Inc. Additionally, Matthew serves on the Advisory Council for the Center for Inclusive Governance at the National Association of Corporate Directors and as a Senior Advisor for Out Leadership. Matthew’s past mentoring role with Women In Bio involved participation in the Boardroom Ready program. Educational qualifications include an MBA from Stanford University Graduate School of Business and a BA in Accounting from the University of Minnesota Duluth.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
10 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.